Developer docs
API playgroundTry for free, no card

Search company profiles

Lumenis

Full company profile

uuid000a5wl

Namestring
Lumenis
Legal namestring
Lumenis Be Ltd.
Websiteurl
lumenis.com
Company typeenum
Private
Founded yearint
1966
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersJerusalem, Israel
HQ citystring
Jerusalem
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
energy-based medical devices, aesthetic laser systems, ophthalmology laser platforms, IPL treatment systems, radiofrequency aesthetic devices
Industry2 codes
1Laser & Energy-Based Dermatology
CodeHLAKACAFPrimaryYes
2Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser)
CodeHLAHADACPrimaryNo
NAICS code4 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
  • Medical Equipment and Supplies Manufacturing3391
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Energy-based medical devices (Aesthetic and Vision)
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Aesthetic Devices
TypeHardware Sales
Description

Sale of capital equipment platforms (Stellar M22, triLift, SPLENDOR X, LightSheer QUATTRO, UltraPulse, FoLix) and consumables/accessories to aesthetic practitioners including dermatologists, plastic surgeons, and medspas

lumenis.com
2Ophthalmology/Vision Devices
TypeHardware Sales
Description

Sale of laser systems for dry eye treatment (OptiLIGHT, OptiPLUS, OptiLIFT), glaucoma management (Digital Duet, Digital Trio, Selecta Duet/Trio), and retinal photocoagulation to eye care professionals

lumenis.com
3Service and Support
TypeProfessional Services
Description

Aftermarket service, training, and support services for installed device base

lumenis.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 15 records shown
1Pollogen
Description

Consumer aesthetic devices and technologies for at-home use

lumenis.com
+14 more records
Core offering1 text field

Lumenis develops, manufactures, and commercializes energy-based medical devices using laser, Intense Pulsed Light (IPL), and radio-frequency (RF) technologies for the Aesthetic and Vision markets. The company sells capital equipment platforms (e.g., Stellar M22, triLift, FoLix, SPLENDOR X, ULTRApulse Alpha, OptiLIGHT) along with consumables, training, and aftermarket service to hospitals, dermatologists, plastic surgeons, ophthalmologists, medspas, and hair restoration practices across 88+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 76-100% clearance of vascular and pigmented lesions after a single XPL session on Stellar M22
+4 more records
Product overview1 text field

Lumenis offers a comprehensive portfolio of energy-based medical devices for the Aesthetic and Vision markets. The Aesthetic portfolio includes platforms for facial muscle stimulation (triLift), hair removal (SPLENDOR X, LightSheer QUATTRO), skin resurfacing (ULTRApulse Alpha, AcuPulse), hair loss treatment (FoLix), skin rejuvenation (Stellar M22, M22), body treatments (NuEra Tight, Legend Pro+), and women's health (FemTouch). The Vision portfolio addresses dry eye (OptiLIGHT, OptiLIFT, OptiPLUS), glaucoma (Digital Duet, Digital Trio, Smart Selecta Duet/Trio), and retina (Smart532, Vision One, Array LaserLink, LumeProbe). The products utilize core technologies including CO2 and diode lasers, IPL (Intense Pulsed Light), Nd:YAG, radiofrequency (RF), and dynamic muscle stimulation. These are primarily modular platform systems with multiple handpieces and treatment modes, sold to hospitals, aesthetic clinics, and ophthalmology practices worldwide.

Product and service23 records
1FoLix
CategoryAesthetic Laser Devices
Description

FDA-cleared non-ablative fractional laser device for hair loss treatment that uses precise pulses of laser light to stimulate hair follicles in adult males and females with Fitzpatrick skin types I-IV. Targeted at hair restoration practices and aesthetic clinics.

2triLift
3Stellar M22
CategoryAesthetic Multi-Application Platforms
Description

Multi-application aesthetic platform with XPL (Expert Pulsed Light) technology integrating four advanced technologies for treating over 30 skin and hair indications across all skin types. Sold to dermatologists, plastic surgeons, and aesthetic clinics.

4SPLENDOR X
CategoryAesthetic Hair Removal Devices
Description

Laser hair removal platform combining Alexandrite and Nd:YAG lasers powered by BLEND X technology for effective hair removal across all skin types. Sold to aesthetic clinics, medspas, and dermatology practices.

5ULTRApulse Alpha
6Legend Pro+
CategoryAesthetic RF Platforms
Description

RF treatment platform combining TriPollar RF, DMA muscle stimulation, and TriFractional technology for skin tightening and body treatments. Sold to aesthetic clinics and medspas.

7LightSheer QUATTRO
CategoryAesthetic Hair Removal Devices
Description

Diode laser hair removal system offering 805nm and 1060nm wavelengths with High Speed Vacuum assisted technology and ChillTip Integrated Contact Cooling for all skin types. Sold to aesthetic practices and medspas.

8NuEra Tight
CategoryAesthetic Body Contouring Devices
Description

Temperature-controlled RF technology platform for skin tightening, body contouring, and cellulite treatment using proprietary RF energy delivery. Sold to aesthetic clinics, medspas, and body contouring practices.

9OptiLIGHT
CategoryOphthalmology IPL Devices
Description

IPL-based dry eye treatment device that addresses the root cause of evaporative dry eye disease through targeted light therapy on the periorbital area. Sold to ophthalmologists and eye care practices.

10OptiLIFT
CategoryOphthalmology Muscle Stimulation Devices
Description

Non-surgical dynamic muscle stimulation device for the periorbital area that tones muscles to address droopy eyelids and impaired blinking, with Health Canada approval. Sold to ophthalmologists and eye care practices.

11OptiPLUS
CategoryOphthalmology RF Devices
Description

Dual-frequency RF technology device that complements OptiLIGHT's dry eye solution by providing additional therapeutic benefits. Sold to ophthalmologists and eye care practices.

12Digital Duet
CategoryOphthalmology Glaucoma Laser Platforms
Description

All-in-one digital platform combining SLT and YAG lasers for glaucoma therapy and posterior capsule opacification (PCO) treatment. Sold to ophthalmologists.

13Digital Trio
CategoryOphthalmology Glaucoma Laser Platforms
Description

3-in-1 digital platform combining SLT, YAG, and retina care capabilities for comprehensive glaucoma and retina treatment. Sold to ophthalmology practices.

14Smart532
CategoryOphthalmology Photocoagulators
Description

Green photocoagulator with SmartPulse sub-threshold technology for retinal treatments with optimized energy delivery. Sold to ophthalmologists and retinal specialists.

15Vision One
CategoryOphthalmology Photocoagulators
Description

Multi-wavelength photocoagulator offering green, yellow, and red wavelengths for versatile retinal treatment options. Sold to ophthalmologists and retinal specialists.

16Array LaserLink
CategoryOphthalmology Photocoagulators
Description

Pattern scanning laser technology for retinal photocoagulation with enhanced precision and efficiency. Sold to ophthalmologists and retinal specialists.

17LumeProbe
CategoryOphthalmic Surgical Accessories
Description

Premium ophthalmic endophotocoagulation laser probes for retinal procedures, available in straight, curved, illuminated, and aspirating types in 20, 23, and 25 gauge sizes. Sold to ophthalmic surgeons.

18Smart Selecta Duet
CategoryOphthalmology Glaucoma Laser Platforms
Description

SLT and YAG photodisruptor combination platform for glaucoma care in one compact system. Sold to ophthalmologists.

19Smart Selecta Trio
CategoryOphthalmology Glaucoma Laser Platforms
Description

Comprehensive platform combining SLT, YAG, and Smart532 for retinal, cataract, and glaucoma therapy. Sold to ophthalmology practices.

20Novus Spectra
CategoryOphthalmology Photocoagulators
Description

Green dual-port photocoagulator for operating room and clinic use in retinal treatments. Sold to ophthalmologists and hospitals.

21M22
CategoryAesthetic Multi-Application Platforms
Description

Aesthetic platform for IPL and laser treatments including skin rejuvenation, pigmentation, vascular lesions, and hair removal. Sold to dermatology and aesthetic practices.

22AcuPulse
CategoryAesthetic CO2 Laser Systems
Description

CO2 laser system for aesthetic and surgical applications including skin resurfacing, with variants for women's health. Sold to hospitals, plastic surgeons, and dermatology practices.

23FemTouch
CategoryAesthetic CO2 Laser Systems
Description

CO2 laser-based vaginal health treatment for women's health indications including vaginal atrophy and stress urinary incontinence. Sold to OB/GYN practices, urogynecologists, and women's health clinics.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-09-24
Description

Bosley, the largest hair restoration practice in the United States, became the first national hair restoration medical practice to offer FoLix FDA-cleared fractional laser for hair loss treatment. Partnership initiated September 2024 at Beverly Hills location with plans to expand nationwide.

Strategic tierFlagshipTypeChannel Partner/ Reseller/ Distributor
Description

Premium London wellness clinic partnership establishing excellence positioning for Lumenis aesthetic treatments in luxury retail healthcare setting.

3Brad Oliver, President of Lumenis Americas
Strategic tierCoreTypeOthers
Description

Executive leadership driving Americas expansion and partnership development for FoLix and other product launches in North American market.

lumenis.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Lumenis Cares Foundation supports Street Child charity focusing on children's education and protection in underserved communities globally.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Non-profit organization at Royal College of Surgeons Ireland working with Lumenis to eliminate preventable blindness in Africa through SLT glaucoma treatment technology.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Social organization in India committed to eliminating needless blindness, collaborating with Lumenis on Selective Laser Trabeculoplasty research to minimize glaucoma progression.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Rox Anderson-led center collaborating on burn treatment missions using Lumenis UltraPulse laser technology in Russia, China, Vietnam, and Armenia.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Leading U.S. eye hospital partnering with Lumenis to provide SLT procedures to underserved patients in Philadelphia.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Humanitarian medical mission partnership providing BPH treatment using VersaPulse PowerSuite holmium laser technology with Dr. Mitchell Humphreys of Mayo Clinic.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Lumenis HOPE campaign helping wounded U.S. soldiers access advanced burn treatment with UltraPulse SCAAR FX CO2 laser regardless of ability to pay.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Alma Lasers is a leading competitor in aesthetic lasers, IPL, RF, and ultrasound platforms for hair removal, skin resurfacing, and body treatments — competing head-to-head with Lumenis across multiple product categories and geographies.

TypeBroad incumbent
Description

AbbVie/Allergan Aesthetics is a broad incumbent in medical aesthetics (Botox, CoolSculpting, SkinMedica) — operating in adjacent categories to Lumenis and competing for the same dermatology and medspa customer wallet, though not in laser/IPL/RF devices.

TypeDirect peer
Description

Cutera is a direct competitor offering laser and energy-based aesthetic platforms including AviClear (acne), excel V (vascular), and truSculpt (body contouring) — competing in overlapping indications with Lumenis' Stellar M22 and body platforms.

TypeDirect peer
Description

Cynosure is a direct competitor in energy-based aesthetic devices (lasers, IPL, RF) for hair removal, skin rejuvenation, and body contouring serving dermatology and medspa customers globally — directly overlapping with Lumenis' Stellar M22, SPLENDOR X, and triLift platforms.

TypeDirect peer
Description

InMode develops RF-based aesthetic platforms (Morpheus8, Evolve, BodyTite) for body contouring and skin remodeling — overlapping with Lumenis' Legend Pro+, NuEra Tight, and RF micro-needling offerings.

TypeDirect peer
Description

BTL Industries competes with Lumenis in non-invasive body contouring, skin tightening, and muscle stimulation (EMSCULPT, EMSELLA) — directly comparable to triLift/Body platforms and NuEra Tight.

TypeDirect peer
Description

Sciton is a privately held direct competitor offering aesthetic laser and light platforms (BBL, Halo, MOXI, Profractional) — closely comparable to Lumenis' skin rejuvenation and resurfacing devices.

TypeDirect peer
Description

Candela (formerly Syneron-Candela) is a direct competitor offering aesthetic and medical laser systems for hair removal, skin treatments, and women's health — directly comparable to Lumenis' aesthetic platform portfolio.

TypeDirect peer
Description

Iridex is a direct competitor in ophthalmic laser systems for glaucoma and retinal treatments — comparable to Lumenis' Digital Duet, Smart Selecta, and photocoagulator vision portfolio.

TypeDirect peer
Description

Solta Medical offers the Thermage, Fraxel, Clear+Brilliant, and Vaser platforms for skin tightening, resurfacing, and body contouring — overlapping directly with Lumenis' ULTRApulse Alpha and skin rejuvenation portfolio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lumenis

Energy-based medical devices (Aesthetic and Vision)lumenis.com

Lumenis firmographics

Firmographics
Name
Lumenis
Legal name
Lumenis Be Ltd.
Website
https://lumenis.com
Company type
Private
Founded year
1966
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Lumenis industry classification

Industry
Product category
Energy-based medical devices (Aesthetic and Vision)
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Laser & Energy-Based Dermatology (HLAKACAF)
akta.pro secondary industry
Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser) (HLAHADAC)

Keywords

  • Energy-based medical devices
  • Aesthetic laser systems
  • Ophthalmology laser platforms
  • IPL treatment systems
  • Radiofrequency aesthetic devices

Where Lumenis is headquartered

Location

Headquarters

HQ city
Jerusalem
HQ country
Israel
HQ region
Middle East

Offices5 records

Markets served

Lumenis business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Medical Aesthetic Devices: Sale of capital equipment platforms (Stellar M22, triLift, SPLENDOR X, LightSheer QUATTRO, UltraPulse, FoLix) and consumables/accessories to aesthetic practitioners including dermatologists, plastic surgeons, and medspas
  2. Ophthalmology/Vision Devices: Sale of laser systems for dry eye treatment (OptiLIGHT, OptiPLUS, OptiLIFT), glaucoma management (Digital Duet, Digital Trio, Selecta Duet/Trio), and retinal photocoagulation to eye care professionals
  3. Service and Support: Aftermarket service, training, and support services for installed device base

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Lumenis product offering

Product offering

Core offering

Lumenis develops, manufactures, and commercializes energy-based medical devices using laser, Intense Pulsed Light (IPL), and radio-frequency (RF) technologies for the Aesthetic and Vision markets. The company sells capital equipment platforms (e.g., Stellar M22, triLift, FoLix, SPLENDOR X, ULTRApulse Alpha, OptiLIGHT) along with consumables, training, and aftermarket service to hospitals, dermatologists, plastic surgeons, ophthalmologists, medspas, and hair restoration practices across 88+ countries.

Product overview

Lumenis offers a comprehensive portfolio of energy-based medical devices for the Aesthetic and Vision markets. The Aesthetic portfolio includes platforms for facial muscle stimulation (triLift), hair removal (SPLENDOR X, LightSheer QUATTRO), skin resurfacing (ULTRApulse Alpha, AcuPulse), hair loss treatment (FoLix), skin rejuvenation (Stellar M22, M22), body treatments (NuEra Tight, Legend Pro+), and women's health (FemTouch). The Vision portfolio addresses dry eye (OptiLIGHT, OptiLIFT, OptiPLUS), glaucoma (Digital Duet, Digital Trio, Smart Selecta Duet/Trio), and retina (Smart532, Vision One, Array LaserLink, LumeProbe). The products utilize core technologies including CO2 and diode lasers, IPL (Intense Pulsed Light), Nd:YAG, radiofrequency (RF), and dynamic muscle stimulation. These are primarily modular platform systems with multiple handpieces and treatment modes, sold to hospitals, aesthetic clinics, and ophthalmology practices worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • Pollogen: Consumer aesthetic devices and technologies for at-home use
  • FoLix
  • triLift
  • Stellar M22
  • OptiLIGHT
  • OptiLIFT
  • OptiPLUS
  • SPLENDOR X
  • ULTRApulse Alpha
  • Legend Pro+
  • LightSheer
  • NuEra Tight
  • M22
  • AcuPulse
  • FemTouch

Products and services

  • FoLix FDA-cleared non-ablative fractional laser device for hair loss treatment that uses precise pulses of laser light to stimulate hair follicles in adult males and females with Fitzpatrick skin types I-IV. Targeted at hair restoration practices and aesthetic clinics.
  • triLift
  • Stellar M22 Multi-application aesthetic platform with XPL (Expert Pulsed Light) technology integrating four advanced technologies for treating over 30 skin and hair indications across all skin types. Sold to dermatologists, plastic surgeons, and aesthetic clinics.
  • SPLENDOR X Laser hair removal platform combining Alexandrite and Nd:YAG lasers powered by BLEND X technology for effective hair removal across all skin types. Sold to aesthetic clinics, medspas, and dermatology practices.
  • ULTRApulse Alpha
  • Legend Pro+ RF treatment platform combining TriPollar RF, DMA muscle stimulation, and TriFractional technology for skin tightening and body treatments. Sold to aesthetic clinics and medspas.
  • LightSheer QUATTRO Diode laser hair removal system offering 805nm and 1060nm wavelengths with High Speed Vacuum assisted technology and ChillTip Integrated Contact Cooling for all skin types. Sold to aesthetic practices and medspas.
  • NuEra Tight Temperature-controlled RF technology platform for skin tightening, body contouring, and cellulite treatment using proprietary RF energy delivery. Sold to aesthetic clinics, medspas, and body contouring practices.
  • OptiLIGHT IPL-based dry eye treatment device that addresses the root cause of evaporative dry eye disease through targeted light therapy on the periorbital area. Sold to ophthalmologists and eye care practices.
  • OptiLIFT Non-surgical dynamic muscle stimulation device for the periorbital area that tones muscles to address droopy eyelids and impaired blinking, with Health Canada approval. Sold to ophthalmologists and eye care practices.
  • OptiPLUS Dual-frequency RF technology device that complements OptiLIGHT's dry eye solution by providing additional therapeutic benefits. Sold to ophthalmologists and eye care practices.
  • Digital Duet All-in-one digital platform combining SLT and YAG lasers for glaucoma therapy and posterior capsule opacification (PCO) treatment. Sold to ophthalmologists.
  • Digital Trio 3-in-1 digital platform combining SLT, YAG, and retina care capabilities for comprehensive glaucoma and retina treatment. Sold to ophthalmology practices.
  • Smart532 Green photocoagulator with SmartPulse sub-threshold technology for retinal treatments with optimized energy delivery. Sold to ophthalmologists and retinal specialists.
  • Vision One Multi-wavelength photocoagulator offering green, yellow, and red wavelengths for versatile retinal treatment options. Sold to ophthalmologists and retinal specialists.
  • Array LaserLink Pattern scanning laser technology for retinal photocoagulation with enhanced precision and efficiency. Sold to ophthalmologists and retinal specialists.
  • LumeProbe Premium ophthalmic endophotocoagulation laser probes for retinal procedures, available in straight, curved, illuminated, and aspirating types in 20, 23, and 25 gauge sizes. Sold to ophthalmic surgeons.
  • Smart Selecta Duet SLT and YAG photodisruptor combination platform for glaucoma care in one compact system. Sold to ophthalmologists.
  • Smart Selecta Trio Comprehensive platform combining SLT, YAG, and Smart532 for retinal, cataract, and glaucoma therapy. Sold to ophthalmology practices.
  • Novus Spectra Green dual-port photocoagulator for operating room and clinic use in retinal treatments. Sold to ophthalmologists and hospitals.
  • M22 Aesthetic platform for IPL and laser treatments including skin rejuvenation, pigmentation, vascular lesions, and hair removal. Sold to dermatology and aesthetic practices.
  • AcuPulse CO2 laser system for aesthetic and surgical applications including skin resurfacing, with variants for women's health. Sold to hospitals, plastic surgeons, and dermatology practices.
  • FemTouch CO2 laser-based vaginal health treatment for women's health indications including vaginal atrophy and stress urinary incontinence. Sold to OB/GYN practices, urogynecologists, and women's health clinics.

Quantifiable outcome

  • 76-100% clearance of vascular and pigmented lesions after a single XPL session on Stellar M22
  • +4 more outcomes

Companies that use Lumenis

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles5 records

Lumenis technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Lumenis partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core, flagship and minor.

  • BosleycoreChannel Partner/ Reseller/ Distributor · 24 September 2024Bosley, the largest hair restoration practice in the United States, became the first national hair restoration medical practice to offer FoLix FDA-cleared fractional laser for hair loss treatment. Partnership initiated September 2024 at Beverly Hills location with plans to expand nationwide.
  • Harrods Wellness ClinicflagshipChannel Partner/ Reseller/ DistributorPremium London wellness clinic partnership establishing excellence positioning for Lumenis aesthetic treatments in luxury retail healthcare setting.
  • Brad Oliver, President of Lumenis AmericascoreOthersExecutive leadership driving Americas expansion and partnership development for FoLix and other product launches in North American market.
  • Street ChildminorStrategic or Co-development PartnerLumenis Cares Foundation supports Street Child charity focusing on children's education and protection in underserved communities globally.
  • Right-to-SightminorStrategic or Co-development PartnerNon-profit organization at Royal College of Surgeons Ireland working with Lumenis to eliminate preventable blindness in Africa through SLT glaucoma treatment technology.
  • Aravind Eye Care SystemminorStrategic or Co-development PartnerSocial organization in India committed to eliminating needless blindness, collaborating with Lumenis on Selective Laser Trabeculoplasty research to minimize glaucoma progression.
  • Wellman Center for Photomedicine (Harvard Medical School)minorStrategic or Co-development PartnerDr. Rox Anderson-led center collaborating on burn treatment missions using Lumenis UltraPulse laser technology in Russia, China, Vietnam, and Armenia.
  • Wills Eye InstituteminorStrategic or Co-development PartnerLeading U.S. eye hospital partnering with Lumenis to provide SLT procedures to underserved patients in Philadelphia.
  • St. Luke Foundation for HaitiminorStrategic or Co-development PartnerHumanitarian medical mission partnership providing BPH treatment using VersaPulse PowerSuite holmium laser technology with Dr. Mitchell Humphreys of Mayo Clinic.
  • Wounded Warriors ProjectminorStrategic or Co-development PartnerLumenis HOPE campaign helping wounded U.S. soldiers access advanced burn treatment with UltraPulse SCAAR FX CO2 laser regardless of ability to pay.

Scale indicators12 records

Recent moves7 records

Expansion highlights5 records

Lumenis competitors and assessment

Company assessment

Direct peers

  • Alma Lasers: Alma Lasers is a leading competitor in aesthetic lasers, IPL, RF, and ultrasound platforms for hair removal, skin resurfacing, and body treatments — competing head-to-head with Lumenis across multiple product categories and geographies.
  • Cutera: Cutera is a direct competitor offering laser and energy-based aesthetic platforms including AviClear (acne), excel V (vascular), and truSculpt (body contouring) — competing in overlapping indications with Lumenis' Stellar M22 and body platforms.
  • Cynosure (Hologic): Cynosure is a direct competitor in energy-based aesthetic devices (lasers, IPL, RF) for hair removal, skin rejuvenation, and body contouring serving dermatology and medspa customers globally — directly overlapping with Lumenis' Stellar M22, SPLENDOR X, and triLift platforms.
  • InMode: InMode develops RF-based aesthetic platforms (Morpheus8, Evolve, BodyTite) for body contouring and skin remodeling — overlapping with Lumenis' Legend Pro+, NuEra Tight, and RF micro-needling offerings.
  • BTL Industries: BTL Industries competes with Lumenis in non-invasive body contouring, skin tightening, and muscle stimulation (EMSCULPT, EMSELLA) — directly comparable to triLift/Body platforms and NuEra Tight.
  • Sciton: Sciton is a privately held direct competitor offering aesthetic laser and light platforms (BBL, Halo, MOXI, Profractional) — closely comparable to Lumenis' skin rejuvenation and resurfacing devices.
  • Candela Corporation: Candela (formerly Syneron-Candela) is a direct competitor offering aesthetic and medical laser systems for hair removal, skin treatments, and women's health — directly comparable to Lumenis' aesthetic platform portfolio.
  • Iridex Corporation: Iridex is a direct competitor in ophthalmic laser systems for glaucoma and retinal treatments — comparable to Lumenis' Digital Duet, Smart Selecta, and photocoagulator vision portfolio.
  • Solta Medical (Bausch Health): Solta Medical offers the Thermage, Fraxel, Clear+Brilliant, and Vaser platforms for skin tightening, resurfacing, and body contouring — overlapping directly with Lumenis' ULTRApulse Alpha and skin rejuvenation portfolio.

Broad incumbents

  • AbbVie (Allergan Aesthetics): AbbVie/Allergan Aesthetics is a broad incumbent in medical aesthetics (Botox, CoolSculpting, SkinMedica) — operating in adjacent categories to Lumenis and competing for the same dermatology and medspa customer wallet, though not in laser/IPL/RF devices.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Lumenis social profiles

Digital presence

Lumenis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lumenis leadership team

Management profile

Number of profiles

Profiles13 records

Lumenis subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Lumenis funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lumenis M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lumenis

What does Lumenis do?

Lumenis develops, manufactures, and commercializes energy-based medical devices using laser, Intense Pulsed Light (IPL), and radio-frequency (RF) technologies for the Aesthetic and Vision markets. The company sells capital equipment platforms (e.g., Stellar M22, triLift, FoLix, SPLENDOR X, ULTRApulse Alpha, OptiLIGHT) along with consumables, training, and aftermarket service to hospitals, dermatologists, plastic surgeons, ophthalmologists, medspas, and hair restoration practices across 88+ countries.

Is Lumenis a public or private company?

Lumenis is a private company. It is classified as private equity controlled and is currently operating.

When was Lumenis founded?

Lumenis was founded in 1966. It employs 1,001 to 5,000 people.

Where is Lumenis based?

Lumenis is headquartered in Jerusalem, Israel, in the Middle East region.

How does Lumenis make money?

Three revenue lines are on record. Medical Aesthetic Devices are the primary driver. The others are ophthalmology/Vision Devices and service and Support.

Who are Lumenis's main competitors?

Direct peers on record are Alma Lasers, Cutera, Cynosure (Hologic), InMode, BTL Industries, Sciton, Candela Corporation, Iridex Corporation and Solta Medical (Bausch Health). AbbVie (Allergan Aesthetics) is listed as a broad incumbent.

Does Lumenis have an API?

No public API is recorded for Lumenis.

What industry is Lumenis in?

Lumenis's product category is Energy-based medical devices (Aesthetic and Vision). Its primary akta.pro industry code is HLAKACAF, Laser & Energy-Based Dermatology, with a secondary code of HLAHADAC, Energy-Based Surgical Devices (Electrosurgery, RF, Ultrasonic, Laser). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Industry TodayMedical Beauty Lasers Market Worth USD 7,955.0 Million by 2035 Amid Rising Demand for Aesthetic TreatmentsA market report by Transparency Market Research projects the global Medical Beauty Lasers Market will grow from USD 3,200.0 million in 2024 to USD 7,955.0 million by 2035, representing a compound annual growth rate of 8.3%. Key drivers include rising demand for minimally invasive cosmetic procedures, technological advancements in laser systems, an aging population seeking anti-aging treatments, and the rapid expansion of medical spas offering aesthetic services. The report identifies North America as the current market leader while Asia-Pacific is forecast to register the fastest growth, with key players including Candela Corporation, Cutera, Inc., Lumenis Be Ltd., and Sciton among others.EIN PresswireHow Companies Compete in the Energy-Based Aesthetic Devices Market: Insights into Market LeadershipCynosure Inc. led global sales in 2024 with a 2% market share in the energy-based aesthetic devices market. The top 10 players held 11% of total revenue, reflecting a fragmented market with moderate entry barriers. Advanced multi-modality platforms and AI-driven imaging are key competitive trends.openPR.comLaser Hair Loss Treatment Market (2026) | How Are Dermatology Clinics Adopting Laser Hair Regrowth Technologies?DataM Intelligence published a market research report on the global laser hair loss treatment market, projecting a 12.0% CAGR during 2024–2031, with North America accounting for 48.5% of revenue. The report documents significant M&A and funding activity across the sector, including Henkel's $1.4 billion acquisition of OLAPLEX and Pelage Pharmaceuticals securing $120 million in funding for its regenerative hair loss therapy. Multiple companies — including Capillus, Lumenis, Lexington International, and Bosley Medical Group — advanced their laser and AI-integrated hair regrowth device portfolios, while firms in Japan such as Aderans, Panasonic Holdings, and Shiseido developed new scalp laser and red-light therapy products.GlobeNewswireLumenis Stellar M22™ with XPL Technology Named “Best New Dermatology Technology Solution” in 2026 MedTech Breakthrough Awards ProgramLumenis Be. Ltd.'s Stellar M22™ with XPL Technology was selected as the winner of the "Best New Dermatology Technology Solution" award in the 10th annual MedTech Breakthrough Awards Program. The FDA-cleared platform integrates four advanced technologies, including the proprietary XPL™ Expert Pulsed Light system, designed to treat over 30 indications across all skin types, and has been backed by 170 clinical studies. With over 30,000 installations worldwide, the device is trusted by leading hospitals globally and has demonstrated 76–100% clearance of vascular and pigmented lesions after a single XPL session.Business InsiderThe Skincare Guru Hollywood Stars Trust for Red-Carpet SkinIsraeli skincare entrepreneur Keren Bartov has built a luxury facial and skincare business serving A-list celebrities including Kim Kardashian, Beyoncé, and Gal Gadot, operating clinics in Tel Aviv and London's Notting Hill neighborhood. Her treatments cost $500 to $900 and incorporate medical-grade devices sourced from companies like DEKA and Lumenis, with her clinic equipment estimated to be worth millions. Bartov launched her own skincare brand in 2018 and a $2,200 at-home device in 2025, with plans to open a permanent US location and expand her pop-up presence during awards season.GlobeNewswireLumenis Stellar M22™ with XPL Technology Named “Best New Dermatology Technology Solution” in 2026 MedTech Breakthrough Awards ProgramLumenis' Stellar M22 platform won Best New Dermatology Technology Solution in the 2026 MedTech Breakthrough Awards. The FDA-cleared device integrates XPL, ResurFX, and other technologies, with clinical data showing 76–100% clearance of vascular and pigmented lesions after a single XPL session.PR NewswireLumenis Aesthetics Showcases New Clinical Data Across Skin and Hair Loss Indications at 45th Annual American Society for Laser Medicine and Surgery ConferenceLumenis Be Ltd. presented new clinical data from its portfolio of energy-based medical devices at the 45th Annual American Society for Laser Medicine and Surgery Conference in Savannah, Georgia from May 7-9, 2026. Key findings included data showing that FoLix, the FDA-cleared non-ablative fractional laser for hair loss, demonstrated statistically significant improvements in hair count and follicular density among androgenetic alopecia patients, with up to 82% showing measurable benefit. Additional data highlighted ULTRApulse Alpha CO2 laser efficacy for rhinophyma treatment with 100% patient satisfaction, and Stellar M22 XPL technology advancements for large-area skin treatments.openPR.comAnti-Aging Services Industry Gains Momentum from USD 40.44 Billion in 2026, Driven by Allergan Aesthetics, Galderma S.A., Lumenis, Cynosure, CuteraFact.MR has published market research projecting the global anti-aging services market to grow from USD 40.44 billion in 2026 to USD 67.77 billion by 2036, at a 5.3% CAGR, driven by rising demand for minimally invasive procedures, expanding clinical infrastructure, and increasing per-patient spending. The report identifies key growth drivers including the shift from reactive treatments to proactive aging management, the expansion of medical spas and aesthetic clinics, and strong adoption in Asia-Pacific as the fastest-growing region. Allergan Aesthetics, Galderma, Cynosure, Lumenis, and Cutera are highlighted as leading competitors shaping the competitive landscape through technology innovation and clinical outcomes.Straits ResearchTattoo Removal Market Size, Trends and Growth Analysis Report 2034The global tattoo removal market was valued at USD 980.39 million in 2025 and is projected to reach USD 2,098.90 million by 2034, growing at a CAGR of 8.85% during the forecast period (2026-2034). North America dominated the market with a 39.57% share in 2025, while Asia Pacific is expected to be the fastest-growing region at a CAGR of 11.04%. The market is driven by advancements in multi-wavelength laser platforms, rising tattoo regret rates, and expanding acceptance of minimally invasive dermatological procedures, with key players including Cynosure Inc., Cutera Inc., Lumenis Ltd., Candela Medical, and Alma Lasers.openPR.comGlobal Portable Diode Laser Hair Removal Machines Market Size is Expected to Reach USD 1,154.83 Million by 2026According to WENKH Research, the global portable diode laser hair removal machines market is projected to grow from USD 1,154.83 million in 2026 to USD 2,870.23 million by 2033, representing a compound annual growth rate of approximately 13.89%. North America remains the largest regional market, with an estimated value of $426 million in 2026, accounting for roughly 36.91% of global market share, driven by a mature medical aesthetics industry and strong consumer purchasing power. Key market players including Lumenis, Alma, Cynosure, and Lutronic collectively hold significant market influence, with the top five manufacturers accounting for approximately 31% of total market share.